Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Nitrosamines Testing market size was valued at USD 119.32 million in 2022 and is expected to expand at a CAGR of 9.85% during the forecast period, reaching USD 209.64 million by 2028.
Nitrosamine Testing is a method to detect the presence and quantity of nitrosamines in foods or medicines.
Nitrosamines are a class of carcinogen impurities, which are formed by the reaction of secondary amines, amides, carbamates, derivatives of urea and nitrite or other nitrogenous compounds with nitrogen in the +3 state. Nitrosamines became a greater focus for the pharmaceutical industry following a series of recalls related to contamination. Nitrosamines can be found in low concentrations in a variety of sources, including API’s and Excipients.
Influence of COVID-19 Outbreak on Nitrosamines Testing Industry Development
COVID-19 has a great impact on small and medium-sized private enterprises represented by catering, tourism, manufacturing and so on, and some Nitrosamines Testing are also facing severe challenges to varying degrees.
Due to the influence of COVID-19, the delayed resumption of work due to the request of the local government will directly affect the failure of the project to be completed and delivered on time. Measures such as stopping production or restricting the flow of personnel and materials are also taken in the place where the labor and consumables required by Nitrosamines Testing are located, which indirectly affects the progress. At the same time, due to the influence of COVID-19, labor and consumables are in short supply and related expenses are rising, resulting in a substantial increase in costs.
In the short term, the most fundamental negative impact of COVID19 on Nitrosamines Testing Industry is the funding problem, especially the cash flow difficulties of small, medium and micro testing enterprises continue to enlarge. capital is the lifeline of enterprises, and solving the short-term capital problem is the first priority for enterprises to survive. Enterprises can solve the problem of short-term capital turnover through accounts receivable factoring, capital borrowing, tripartite contract mortgage pawn, mutual insurance, joint insurance and other forms.
In the long-term, COVID-19 has promoted the development of Nitrosamines Testing Industry. Under the impact of COVID-19, many small and medium-sized enterprises have closed down, which is equivalent to an industry reshuffle, the survival of the fittest, and helping the industry to adjust the market.
On the other hand, COVID-19 has increased the R&D and production of related drugs. Nitrosamines Testing is essential in the process of drugs from R&D to market.
Limitations
In recent years, various pharmaceutical products (DPs) have been recalled from the market due to the detection of nitrosamine impurities. In order to identify the source of nitrosamine impurities in pharmaceutical products, various drug regulatory agencies and the entire pharmaceutical industry have conducted extensive investigations. The US FDA listed at least seven possible root causes for the introduction of nitrosamine impurities in the latest version of the guidance (2020), and the latest EMA guidance also published 11 possible sources. The diversity and uncertainty of such sources make it extremely difficult to accurately detect nitrosamine impurities in pharmaceuticals.
If both secondary amines and nitrites are present under acidic conditions, the two may react to form nitrosamine impurities. In addition to the material itself with a secondary amine structure, tertiary amines and quaternary ammonium reagents may also introduce secondary amine impurities; Amide reagents are also considered another source of secondary amines. In addition, contamination of raw materials purchased from suppliers may also introduce nitrosamine-like impurities. If recycled materials such as solvents, reagents and catalysts are used in the production process, there also may be a risk of introducing nitrosamine-like impurities due to impurities such as residual amines.
Region Overview:
From 2023-2028, North America is estimated to witness robust growth prospects.
Company Overview:
Eurofins is one of the major players operating in the Nitrosamines Testing market, holding a share of 19.91% in 2022.
Eurofins providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.
SGS is engages in the provision of inspection, verification, testing, certification and quality assurance services. It operates through the following segments: Agriculture, Food and Life; Mineral Services; Oil, Gas and Chemicals Services; Consumer and Retail Services; Certification and Business Enhancement; Industrial Services; Environment, Health and Safety Services; Transportation Services; and Governments and Institutions Services. The company was founded in 1878 and is headquartered in Geneva, Switzerland.
Segmentation Overview:
Among different product types, Gas Chromatography and Mass Spectrometry segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Pharmaceutical Industry segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Nitrosamines Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Nitrosamines Testing. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Nitrosamines Testing Market Report Include:
Market Size Estimates: Nitrosamines Testing market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Nitrosamines Testing market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Nitrosamines Testing market
Segment Market Analysis: Nitrosamines Testing market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Nitrosamines Testing market situations and prospects in major and top regions and countries
Nitrosamines Testing Market
Nitrosamines Testing Industry Chain: Nitrosamines Testing market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Nitrosamines Testing Industry News, Policies by regions
Nitrosamines Testing Industry Porters Five Forces Analysis
Key players in the global Nitrosamines Testing market are covered in Chapter 2:
SGS
Nucro-Technics
Canadian Analytical Laboratories
Selvita
EKG Life Science Solutions, LLC (EKG Labs)
Alcami Corporation, Inc.
Boston Analytical
Eurofins
AMPAC Analytical
KYMOS Group
In Chapter 6 and Chapter 9, on the basis of types, the Nitrosamines Testing market from 2018 to 2028 is primarily split into:
Liquid Chromatography and Mass Spectrometry
Gas Chromatography and Mass Spectrometry
In Chapter 7 and Chapter 10, on the basis of applications, the Nitrosamines Testing market from 2018 to 2028 covers:
Pharmaceutical Industry
Chemical Industry
Food Industry
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Nitrosamines Testing market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Nitrosamines Testing industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Nitrosamines Testing market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Nitrosamines Testing industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Nitrosamines Testing market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Nitrosamines Testing market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Nitrosamines Testing market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Nitrosamine Testing is a method to detect the presence and quantity of nitrosamines in foods or medicines.
Nitrosamines are a class of carcinogen impurities, which are formed by the reaction of secondary amines, amides, carbamates, derivatives of urea and nitrite or other nitrogenous compounds with nitrogen in the +3 state. Nitrosamines became a greater focus for the pharmaceutical industry following a series of recalls related to contamination. Nitrosamines can be found in low concentrations in a variety of sources, including API’s and Excipients.
Influence of COVID-19 Outbreak on Nitrosamines Testing Industry Development
COVID-19 has a great impact on small and medium-sized private enterprises represented by catering, tourism, manufacturing and so on, and some Nitrosamines Testing are also facing severe challenges to varying degrees.
Due to the influence of COVID-19, the delayed resumption of work due to the request of the local government will directly affect the failure of the project to be completed and delivered on time. Measures such as stopping production or restricting the flow of personnel and materials are also taken in the place where the labor and consumables required by Nitrosamines Testing are located, which indirectly affects the progress. At the same time, due to the influence of COVID-19, labor and consumables are in short supply and related expenses are rising, resulting in a substantial increase in costs.
In the short term, the most fundamental negative impact of COVID19 on Nitrosamines Testing Industry is the funding problem, especially the cash flow difficulties of small, medium and micro testing enterprises continue to enlarge. capital is the lifeline of enterprises, and solving the short-term capital problem is the first priority for enterprises to survive. Enterprises can solve the problem of short-term capital turnover through accounts receivable factoring, capital borrowing, tripartite contract mortgage pawn, mutual insurance, joint insurance and other forms.
In the long-term, COVID-19 has promoted the development of Nitrosamines Testing Industry. Under the impact of COVID-19, many small and medium-sized enterprises have closed down, which is equivalent to an industry reshuffle, the survival of the fittest, and helping the industry to adjust the market.
On the other hand, COVID-19 has increased the R&D and production of related drugs. Nitrosamines Testing is essential in the process of drugs from R&D to market.
Limitations
In recent years, various pharmaceutical products (DPs) have been recalled from the market due to the detection of nitrosamine impurities. In order to identify the source of nitrosamine impurities in pharmaceutical products, various drug regulatory agencies and the entire pharmaceutical industry have conducted extensive investigations. The US FDA listed at least seven possible root causes for the introduction of nitrosamine impurities in the latest version of the guidance (2020), and the latest EMA guidance also published 11 possible sources. The diversity and uncertainty of such sources make it extremely difficult to accurately detect nitrosamine impurities in pharmaceuticals.
If both secondary amines and nitrites are present under acidic conditions, the two may react to form nitrosamine impurities. In addition to the material itself with a secondary amine structure, tertiary amines and quaternary ammonium reagents may also introduce secondary amine impurities; Amide reagents are also considered another source of secondary amines. In addition, contamination of raw materials purchased from suppliers may also introduce nitrosamine-like impurities. If recycled materials such as solvents, reagents and catalysts are used in the production process, there also may be a risk of introducing nitrosamine-like impurities due to impurities such as residual amines.
Region Overview:
From 2023-2028, North America is estimated to witness robust growth prospects.
Company Overview:
Eurofins is one of the major players operating in the Nitrosamines Testing market, holding a share of 19.91% in 2022.
Eurofins providing testing and support services to the pharmaceutical, food, environmental, agriscience and consumer products industries and to governments.
SGS is engages in the provision of inspection, verification, testing, certification and quality assurance services. It operates through the following segments: Agriculture, Food and Life; Mineral Services; Oil, Gas and Chemicals Services; Consumer and Retail Services; Certification and Business Enhancement; Industrial Services; Environment, Health and Safety Services; Transportation Services; and Governments and Institutions Services. The company was founded in 1878 and is headquartered in Geneva, Switzerland.
Segmentation Overview:
Among different product types, Gas Chromatography and Mass Spectrometry segment is anticipated to contribute the largest market share in 2028.
Application Overview:
By application, the Pharmaceutical Industry segment occupied the biggest share from 2018 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Nitrosamines Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Nitrosamines Testing. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Nitrosamines Testing Market Report Include:
Market Size Estimates: Nitrosamines Testing market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Nitrosamines Testing market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Nitrosamines Testing market
Segment Market Analysis: Nitrosamines Testing market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Nitrosamines Testing market situations and prospects in major and top regions and countries
Nitrosamines Testing Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Nitrosamines Testing Industry Chain: Nitrosamines Testing market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Nitrosamines Testing Industry News, Policies by regions
Nitrosamines Testing Industry Porters Five Forces Analysis
Key players in the global Nitrosamines Testing market are covered in Chapter 2:
SGS
Nucro-Technics
Canadian Analytical Laboratories
Selvita
EKG Life Science Solutions, LLC (EKG Labs)
Alcami Corporation, Inc.
Boston Analytical
Eurofins
AMPAC Analytical
KYMOS Group
In Chapter 6 and Chapter 9, on the basis of types, the Nitrosamines Testing market from 2018 to 2028 is primarily split into:
Liquid Chromatography and Mass Spectrometry
Gas Chromatography and Mass Spectrometry
In Chapter 7 and Chapter 10, on the basis of applications, the Nitrosamines Testing market from 2018 to 2028 covers:
Pharmaceutical Industry
Chemical Industry
Food Industry
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Nitrosamines Testing market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Nitrosamines Testing industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Nitrosamines Testing market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Nitrosamines Testing industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Nitrosamines Testing market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Nitrosamines Testing market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Nitrosamines Testing market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
